Etimicin Sulfate Nebuliser Solution(Wuxi Jimincare Shanhe Pharma)

硫酸依替米星雾化吸入溶液(无锡济煜山禾药业)

Report date: 2025/08/14 17:00:02

Base Information

Drug NameEtimicin Sulfate Nebuliser Solution(Wuxi Jimincare Shanhe Pharma)
Drug Alias Name硫酸依替米星雾化吸入溶液(2.2改良型)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsBronchiectasisPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBronchiectasisPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A